Acetylsalicylic Acid combined with Viagra

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Ventricular Extrasystoles Other Serious 1/1/2001 75 Male 204 lb 1/31/2007 Physician United Kingdom
Primary
Concomitant
Respiratory Failure Other Serious 5/27/2005 Male 187 lb 10/19/2007 Lawyer United States
Primary
Secondary
Concomitant
Optic Ischaemic Neuropathy Other Serious 8/1/2005 Male 2/28/2008 Lawyer United States
Primary
Concomitant
Surgery Other Serious 11/13/2008 12/10/2008 Consumer Brazil
Primary
Concomitant
Paralysis Other Serious 5/20/2008 Male 180 lb 12/11/2008 Consumer United States
Primary
Concomitant
Vision Blurred Other Serious 3/1/2007 Male 12/31/2008 Consumer United States
Primary
Concomitant
Paralysis Other Serious 5/20/2008 Male 180 lb 1/5/2009 Consumer United States
Primary
Concomitant
Prostatomegaly Other Serious 1/1/2002 Male 200 lb 1/6/2009 Consumer United States
Primary
Secondary
Concomitant
Retinal Vein Occlusion Other Serious 12/2/2008 Male 210 lb 1/15/2009 Physician United States
Primary
Concomitant
Vision Blurred Other Serious 1/20/2009 Consumer Brazil
Primary
Concomitant
Blindness Other Serious Male 170 lb 1/23/2009 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 2/9/2009 Consumer Brazil
Primary
Concomitant
Optic Ischaemic Neuropathy Other Serious Male 2/12/2009 Lawyer United States
Primary
Concomitant
Surgery Other Serious 11/13/2008 2/19/2009 Consumer Brazil
Primary
Concomitant
Vision Blurred Other Serious Male 2/27/2009 Consumer United States
Primary
Secondary
Haemorrhage Urinary Tract Other Serious 2/1/2009 Male 179 lb 3/10/2009 Consumer United States
Primary
Secondary
Concomitant
Paralysis Other Serious 5/20/2008 Male 180 lb 3/24/2009 Consumer United States
Primary
Concomitant
Vision Blurred Other Serious 3/1/2007 Male 4/3/2009 Consumer United States
Primary
Concomitant
Prostatomegaly Other Serious 1/1/2002 Male 200 lb 4/7/2009 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 2/15/2009 Male 4/17/2009 Consumer United States
Primary
Secondary
Weight Increased Other Serious 3/1/2009 Male 200 lb 4/17/2009 Consumer United States
Primary
Secondary
Concomitant
Stent Placement Other Serious Male 170 lb 4/22/2009 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 3/1/2007 Male 4/24/2009 Consumer United States
Primary
Concomitant
Haemorrhage Urinary Tract Other Serious 2/1/2009 Male 179 lb 5/7/2009 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 2/15/2009 Male 5/14/2009 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 2/15/2009 Male 5/15/2009 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 2/15/2009 Male 5/19/2009 Physician United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 3/1/2009 Male 200 lb 6/2/2009 Consumer United States
Primary
Secondary
Concomitant
Drug Interaction Other Serious 56 6/19/2009 Physician United Kingdom
Primary
Concomitant
Interacting
Vertigo Hospitalization 2/14/2009 Male 185 lb 6/24/2009
Primary
Secondary
Concomitant
Road Traffic Accident Other Serious 1/1/2006 Male 210 lb 6/26/2009 Consumer United States
Primary
Concomitant
Stent Placement Other Serious Male 170 lb 7/2/2009 Physician United States
Primary
Secondary
Concomitant
Urine Colour Abnormal Other Serious 7/1/2008 Male 250 lb 7/2/2009 Consumer United States
Primary
Concomitant
Vertigo Hospitalization 2/14/2009 Male 185 lb 7/21/2009
Primary
Secondary
Concomitant
Optic Ischaemic Neuropathy Other Serious 5/23/2002 Male 9/18/2009 Lawyer United States
Primary
Concomitant
Optic Ischaemic Neuropathy Other Serious 1/31/2005 Male 9/18/2009 Lawyer United States
Primary
Concomitant
Vertigo Other Serious 2/19/2009 Male 185 lb 10/1/2009
Primary
Secondary
Concomitant
Optic Ischaemic Neuropathy Other Serious 8/8/2004 Male 10/1/2009 Lawyer United States
Primary
Concomitant
Vertigo Other Serious 2/19/2009 Male 185 lb 10/16/2009
Primary
Secondary
Concomitant
Myalgia Disability 2/1/2009 52 176 lb 1/13/2010 Other Health Professional United Kingdom
Primary
Concomitant
Haemorrhage Urinary Tract Other Serious 2/1/2009 Male 179 lb 1/14/2010 Consumer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/2009 Male 125 lb 2/4/2010 Consumer United States
Primary
Concomitant
Myalgia Disability 2/1/2009 51 176 lb 2/24/2010 Other Health Professional United Kingdom
Primary
Concomitant
Pain Other Serious Male 212 lb 3/5/2010 Consumer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 12/1/2009 Male 3/16/2010 United States
Primary
Concomitant
Surgery Other Serious 10/1/2009 73 Male 170 lb 4/15/2010 Other Health Professional United States
Primary
Concomitant
Medication Error Other Serious Male 4/19/2010 Consumer United Kingdom
Primary
Concomitant
Sperm Count Decreased Other Serious Male 200 lb 4/27/2010 Consumer United States
Primary
Secondary
Concomitant
Peripheral Vascular Disorder Other Serious 6/1/2007 41 Male 212 lb 4/28/2010 Consumer United States
Primary
Concomitant
Pollakiuria Other Serious Male 245 lb 4/30/2010 Consumer United States
Primary
Concomitant
Thrombosis Other Serious 1/26/2010 74 Male 195 lb 4/30/2010 Consumer United States
Primary
Concomitant
Sinus Bradycardia Other Serious 10/1/2009 57 Male 238 lb 6/10/2010 Physician United States
Primary
Secondary
Concomitant
Ureteral Disorder Other Serious 1/1/2010 57 Male 228 lb 6/22/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Vision Blurred 10/22/2007 79 Male 170 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Drug Ineffective 1/1/2007 65 Male 165 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 1/1/2007 68 Male 200 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Palpitations 9/1/2007 50 Male 214 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Drug Ineffective 4/24/2007 51 Male 235 lb 6/29/2010 Consumer United States
Primary
Concomitant
Tension Headache 8/24/2007 76 Male 196 lb 6/29/2010 Consumer United States
Primary
Concomitant
Road Traffic Accident Other Serious 1/1/2006 61 Male 210 lb 6/29/2010 Consumer United States
Primary
Concomitant
Vision Blurred 7/1/2003 49 Male 150 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 7/27/2007 43 Male 205 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Frustration 5/24/2005 66 Male 170 lb 6/29/2010 Consumer United States
Primary
Concomitant
Myalgia 10/22/2004 56 Male 210 lb 6/29/2010 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective Male 155 lb 6/29/2010 Consumer United States
Primary
Concomitant
Erectile Dysfunction 1/1/2005 65 Male 220 lb 6/29/2010 Consumer United States
Primary
Concomitant
Epistaxis 9/1/2007 62 Male 180 lb 6/29/2010 Consumer United States
Primary
Concomitant
Spontaneous Penile Erection 1/1/2000 62 Male 235 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Effect Decreased 1/1/2006 47 Male 195 lb 6/29/2010 Consumer United States
Primary
Concomitant
Heart Rate Increased 1/1/2004 50 Male 180 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 3/1/2007 63 Male 130 lb 6/29/2010 Consumer United States
Primary
Concomitant
Urethral Pain 10/1/2007 66 Male 170 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Interaction 1/1/2007 61 Male 201 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Interacting
Paraesthesia 1/1/2007 64 Male 150 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Peyronie's Disease 6/1/2007 67 Male 165 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Nasal Congestion 1/5/2008 54 Male 140 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 7/1/2007 65 Male 190 lb 6/29/2010 Consumer United States
Primary
Concomitant
Deafness Other Serious 1/1/2007 63 Male 220 lb 6/29/2010 Consumer United States
Primary
Concomitant
Dyspareunia 1/1/2006 74 Male 158 lb 6/29/2010 Consumer United States
Primary
Concomitant
Rash 12/17/2007 72 Male 200 lb 6/29/2010 Consumer United States
Primary
Concomitant
Flushing 12/1/2007 75 Male 176 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Male 180 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Vision Blurred Male 6/29/2010 Consumer United States
Primary
Concomitant
Malaise Male 225 lb 6/29/2010 Consumer United States
Primary
Concomitant
Headache 5/1/2007 46 Male 251 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Incorrect Dose Administered Male 244 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nasal Congestion 1/1/2008 61 Male 190 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Drug Ineffective Male 170 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Penis Disorder Male 180 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Male 180 lb 6/29/2010 Consumer United States
Primary
Concomitant
Ejaculation Failure 3/1/2008 77 Male 197 lb 6/29/2010 Consumer United States
Primary
Concomitant
Flushing 1/1/2008 72 Male 175 lb 6/29/2010 Consumer United States
Primary
Concomitant
Erectile Dysfunction 1/1/2006 67 Male 200 lb 6/29/2010 Consumer United States
Primary
Concomitant
Heart Rate Increased 5/10/2008 41 Male 210 lb 6/29/2010 Consumer United States
Primary
Concomitant
Deafness Neurosensory Other Serious 3/31/2008 Male 6/29/2010 Other Health Professional United States
Primary
Concomitant
Drug Ineffective Male 187 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Pain 2/1/2008 64 Male 6/29/2010 Other Health Professional United States
Primary
Concomitant
Vision Blurred Male 149 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Somnolence 1/1/2008 78 Male 160 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 73 Male 183 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Nervousness Male 210 lb 6/29/2010 Consumer United States
Primary
Concomitant
Hypertension 1/1/2000 57 Male 167 lb 6/29/2010 Consumer United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 1/1/2008 60 Male 200 lb 6/29/2010 Consumer United States
Primary
Concomitant
Vomiting 1/1/2008 58 Male 241 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 1/1/2008 71 Male 185 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Drug Effect Decreased 1/1/2008 74 Male 210 lb 6/29/2010 Consumer United States
Primary
Concomitant
Expired Drug Administered 1/1/2008 70 Male 6/29/2010 Consumer United States
Primary
Concomitant
Heart Rate Increased 7/28/2008 48 Male 170 lb 6/29/2010 Consumer United States
Primary
Concomitant
Vision Blurred 8/1/2008 73 Male 190 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Unevaluable Event 9/6/2008 53 Male 225 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 8/1/2008 65 Male 165 lb 6/29/2010 Consumer United States
Primary
Concomitant
Rhinorrhoea 8/1/2008 71 Male 72 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Prostatic Specific Antigen Decreased Male 190 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Prostatic Specific Antigen Increased 1/1/2008 83 Male 165 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nervous System Disorder 1/1/2000 64 Male 190 lb 6/29/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Erectile Dysfunction 10/22/2008 69 Male 226 lb 6/29/2010 Consumer United States
Primary
Concomitant
Headache 1/1/2008 61 Male 170 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Nasopharyngitis Other Serious 9/27/2008 75 Male 190 lb 6/29/2010 Other Health Professional United States
Primary
Concomitant
Erectile Dysfunction Male 291 lb 6/29/2010 Consumer United States
Primary
Concomitant
Headache 9/1/2008 62 Male 341 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Male 195 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nasal Congestion Other Serious 1/1/2008 67 Male 180 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nasal Congestion 12/13/2008 61 Male 210 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Other Serious 1/1/2009 71 Male 160 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 11/1/2008 60 Male 238 lb 6/29/2010 Physician United States
Primary
Concomitant
Scar 1/8/2009 75 Male 180 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nasal Congestion Male 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 7/1/2008 73 Male 375 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Male 6/29/2010 Consumer United States
Primary
Concomitant
Paraesthesia 1/1/2008 55 Male 202 lb 6/29/2010 Consumer United States
Primary
Concomitant
Skin Discolouration 82 Male 6/29/2010 Consumer United States
Primary
Secondary
Drug Ineffective Male 209 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nasal Congestion Male 201 lb 6/29/2010 Consumer United States
Primary
Concomitant
Ocular Hyperaemia 4/29/2009 47 Male 224 lb 6/29/2010 Consumer United States
Primary
Concomitant
Nausea Male 139 lb 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Male 160 lb 6/29/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Tremor Male 190 lb 6/29/2010 Physician United States
Primary
Concomitant
Drug Ineffective 1/1/2009 52 Male 276 lb 6/29/2010 Consumer United States
Primary
Concomitant
Vision Blurred 1/1/2006 70 Male 135 lb 6/29/2010 Consumer United States
Primary
Concomitant
Tinnitus Male 195 lb 6/29/2010 Pharmacist United States
Primary
Concomitant
Interacting
Erectile Dysfunction 1/1/2008 76 Male 185 lb 6/29/2010 Consumer United States
Primary
Concomitant
Spontaneous Penile Erection Other Serious 4/1/2009 40 Male 270 lb 6/29/2010 Physician United States
Primary
Secondary
Concomitant
Drug Ineffective 1/1/2008 70 Male 206 lb 6/29/2010 Consumer United States
Primary
Concomitant
Pruritus 198 lb 6/29/2010 Consumer United States
Primary
Concomitant
Weight Increased 1/1/2009 65 Male 280 lb 6/29/2010 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective 7/1/2009 51 Male 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 8/1/2009 79 Male 155 lb 6/29/2010 Consumer United States
Primary
Concomitant
Self Esteem Decreased Male 240 lb 6/30/2010 Consumer United States
Primary
Concomitant
Upper Airway Obstruction Male 6/29/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 8/1/2009 66 Male 210 lb 6/30/2010 Consumer United States
Primary
Concomitant

Drug Data